Interestingly, long treatment with low doses of Dia2 arrest cell proliferation specifically in MLLr cells carrying MLL-AF9, MLL-ENL, and MLL-AF4 fusions and not in other leukemia cells, as observed with EPZ-5676. This evidence concerns the gene KMT2A and leukemia.